Park Jihye, Welner Robert S, Chan Mei-Yee, Troppito Logan, Staber Philipp B, Tenen Daniel G, Yan Catherine T
Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA 02215; Broad Institute of MIT and Harvard, Cambridge, MA 02142; and.
Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115.
J Immunol. 2016 Jan 1;196(1):244-55. doi: 10.4049/jimmunol.1403099. Epub 2015 Nov 25.
Hypomorphic mutations in the nonhomologous end-joining (NHEJ) DNA repair protein DNA ligase IV (LIG4) lead to immunodeficiency with varying severity. In this study, using a murine knock-in model, we investigated the mechanisms underlying abnormalities in class switch recombination (CSR) associated with the human homozygous Lig4 R278H mutation. Previously, we found that despite the near absence of Lig4 end-ligation activity and severely reduced mature B cell numbers, Lig4(R278H/R278H) (Lig4(R/R)) mice exhibit only a partial CSR block, producing near normal IgG1 and IgE but substantially reduced IgG3, IgG2b, and IgA serum levels. In this study, to address the cause of these abnormalities, we assayed CSR in Lig4(R/R) B cells generated via preassembled IgH and IgK V region exons (HL). This revealed that Lig4(R278H) protein levels while intact exhibited a higher turnover rate during activation of switching to IgG3 and IgG2b, as well as delays in CSR kinetics associated with defective proliferation during activation of switching to IgG1 and IgE. Activated Lig4(R/R)HL B cells consistently accumulated high frequencies of activation-induced cytidine deaminase-dependent IgH locus chromosomal breaks and translocations and were more prone to apoptosis, effects that appeared to be p53-independent, as p53 deficiency did not markedly influence these events. Importantly, NHEJ instead of alternative end-joining (A-EJ) was revealed as the predominant mechanism catalyzing robust CSR. Defective CSR was linked to failed NHEJ and residual A-EJ access to unrepaired double-strand breaks. These data firmly demonstrate that Lig4(R278H) activity renders NHEJ to be more error-prone, and they predict increased error-prone NHEJ activity and A-EJ suppression as the cause of the defective B lymphopoiesis in Lig4 patients.
非同源末端连接(NHEJ)DNA修复蛋白DNA连接酶IV(LIG4)的亚效突变会导致严重程度各异的免疫缺陷。在本研究中,我们使用小鼠基因敲入模型,探究了与人类纯合Lig4 R278H突变相关的类别转换重组(CSR)异常的潜在机制。此前,我们发现尽管Lig4末端连接活性几乎缺失且成熟B细胞数量严重减少,但Lig4(R278H/R278H)(Lig4(R/R))小鼠仅表现出部分CSR阻断,产生的IgG1和IgE水平接近正常,但IgG3、IgG2b和IgA血清水平大幅降低。在本研究中,为了探究这些异常的原因,我们检测了通过预组装的IgH和IgK V区外显子(HL)产生的Lig(R/R)B细胞中的CSR。这表明Lig4(R278H)蛋白水平虽然完整,但在转换为IgG3和IgG2b的激活过程中周转率较高,并且在转换为IgG1和IgE的激活过程中与增殖缺陷相关的CSR动力学延迟。激活的Lig4(R/R)HL B细胞持续积累高频的激活诱导的胞嘧啶脱氨酶依赖性IgH基因座染色体断裂和易位,并且更容易发生凋亡,这些效应似乎与p53无关,因为p53缺陷并未显著影响这些事件。重要的是,NHEJ而非替代末端连接(A-EJ)被揭示为催化强大CSR的主要机制。有缺陷的CSR与失败的NHEJ和残留的A-EJ对未修复双链断裂的利用有关。这些数据有力地证明Lig4(R278H)活性使NHEJ更容易出错,并且预测易错NHEJ活性增加和A-EJ抑制是Lig4患者B淋巴细胞生成缺陷的原因。